catalyst
as of 2026-07-01A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone E — primary completion
at a glance
2020-12-22 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.
Event
What
A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone E — primary completion
Type
Trial Readout
Date
2020-12-22
Date type
ACTUAL
Phase
Phase 2
This event happened.
relationships
The graph out of here